- Home
- ARMP vs TBNK Comparison
ARMP vs TBNK Comparison
Compare ARMP & TBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- TBNK
- Stock Information
- Founded
- ARMP N/A
- TBNK 1921
- Country
- ARMP United States
- TBNK United States
- Employees
- ARMP N/A
- TBNK N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- TBNK Savings Institutions
- Sector
- ARMP Health Care
- TBNK Finance
- Exchange
- ARMP Nasdaq
- TBNK Nasdaq
- Market Cap
- ARMP 80.0M
- TBNK 83.2M
- IPO Year
- ARMP N/A
- TBNK N/A
- Fundamental
- Price
- ARMP $2.72
- TBNK $10.83
- Analyst Decision
- ARMP Strong Buy
- TBNK Hold
- Analyst Count
- ARMP 1
- TBNK 2
- Target Price
- ARMP $7.00
- TBNK $9.89
- AVG Volume (30 Days)
- ARMP 8.3K
- TBNK 33.2K
- Earning Date
- ARMP 11-13-2024
- TBNK 10-28-2024
- Dividend Yield
- ARMP N/A
- TBNK 0.37%
- EPS Growth
- ARMP N/A
- TBNK N/A
- EPS
- ARMP N/A
- TBNK N/A
- Revenue
- ARMP $3,719,000.00
- TBNK $36,203,000.00
- Revenue This Year
- ARMP N/A
- TBNK N/A
- Revenue Next Year
- ARMP $83.33
- TBNK $6.91
- P/E Ratio
- ARMP N/A
- TBNK N/A
- Revenue Growth
- ARMP N/A
- TBNK N/A
- 52 Week Low
- ARMP $1.93
- TBNK $6.92
- 52 Week High
- ARMP $4.48
- TBNK $11.64
- Technical
- Relative Strength Index (RSI)
- ARMP 67.03
- TBNK 53.63
- Support Level
- ARMP $2.21
- TBNK $10.62
- Resistance Level
- ARMP $2.96
- TBNK $11.18
- Average True Range (ATR)
- ARMP 0.15
- TBNK 0.34
- MACD
- ARMP 0.05
- TBNK 0.03
- Stochastic Oscillator
- ARMP 68.42
- TBNK 57.34
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About TBNK Territorial Bancorp Inc.
Territorial Bancorp Inc operates as a bank holding company. It offers a wide variety of FDIC-insured deposit products and loan products for the consumer and small businesses. Its business consists of accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in one-to-four-family residential mortgage loans and investment securities. The company offers a variety of deposit accounts, including passbook and statement savings accounts, certificates of deposit, money market accounts, commercial and regular checking accounts and Super NOW accounts Its loan segment portfolio consists of Residential Mortgage; Construction, Commercial, and Other Mortgage Loans; Home Equity loans & line of credit; and Consumer & others.